NASDAQ:CRSP - Crispr Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$31.52 +0.59 (+1.91 %)
(As of 02/15/2019 04:00 PM ET)
Previous Close$31.52
Today's Range$30.81 - $31.78
52-Week Range$22.22 - $73.90
Volume416,500 shs
Average Volume762,469 shs
Market Capitalization$1.64 billion
P/E Ratio-18.43
Dividend YieldN/A

Analyst Ratings

Crispr Therapeutics (NASDAQ:CRSP) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
12 Wall Street analysts have issued ratings and price targets for Crispr Therapeutics in the last 12 months. Their average twelve-month price target is $52.6920, suggesting that the stock has a possible upside of 67.17%. The high price target for CRSP is $72.50 and the low price target for CRSP is $21.00. There are currently 2 sell ratings, 2 hold ratings and 8 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.502.642.552.75
Ratings Breakdown: 2 Sell Rating(s)
2 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
3 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $52.6920$62.1022$65.0250$65.1714
Price Target Upside: 67.17% upside132.16% upside76.46% upside33.99% upside

Crispr Therapeutics (NASDAQ:CRSP) Consensus Price Target History

Price Target History for Crispr Therapeutics (NASDAQ:CRSP)

Crispr Therapeutics (NASDAQ:CRSP) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/7/2019BTIG ResearchInitiated CoverageBuy$43.00MediumView Rating Details
1/28/2019Goldman Sachs GroupDowngradeBuy ➝ Neutral$78.00 ➝ $40.00LowView Rating Details
1/22/2019CitigroupDowngradeNeutral ➝ Sell$28.00 ➝ $21.00HighView Rating Details
12/31/2018SunTrust BanksReiterated RatingBuyMediumView Rating Details
12/9/2018Needham & Company LLCInitiated CoverageBuy$62.00 ➝ $38.72LowView Rating Details
10/10/2018Wells Fargo & CoInitiated CoverageOutperform ➝ Outperform$65.00HighView Rating Details
10/9/2018GuggenheimInitiated CoverageNeutral ➝ NeutralLowView Rating Details
9/20/2018Raymond JamesInitiated CoverageUnderperform ➝ UnderperformHighView Rating Details
8/8/2018Chardan CapitalReiterated RatingBuy$72.50HighView Rating Details
3/9/2018Piper Jaffray CompaniesReiterated RatingOverweight$67.00 ➝ $53.70HighView Rating Details
3/8/2018JMP SecuritiesInitiated CoverageMkt Outperform ➝ Outperform$69.00HighView Rating Details
3/7/2018BarclaysBoost Price TargetOverweight ➝ Overweight$29.00 ➝ $59.00LowView Rating Details
12/21/2017OppenheimerReiterated RatingHoldHighView Rating Details
(Data available from 2/16/2017 forward)
This page was last updated on 2/16/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel